PUCCI, Ida
PUCCI, Ida
Dipartimento di Oncologia Sperimentale e Applicazioni Cliniche (attivo dal 01/01/2002 al 31/12/2010)
A combined determination of circulating gelatinases and inflammatory markers in breast cancer patients during therapeutic treatment
2008-01-01 MARABETI MR; DI CARA G; CANCEMI P; ALBANESE NN; COSTANTINI F; TAORMINA P; MARRAZZO A; PUCCI-MINAFRA I
A PROTEOMIC CLUSTER FOR OSTEOTROPIC BREAST CANCER CELLS
2014-01-01 Di Cara, G; Musso, R; Albanese, NN; Cancemi, P; Peri, G; Valentino, B; D’Arienzo, M; Martini, D; Raspanti, M; Minafra, S; Pucci, I
Analisi comparativa tra linee cellulari di carcinoma tiroideo papillare ed anaplastico
2013-01-01 Musso, R; Di Cara, G; Albanese, NN; Marabeti, MR; Cancemi, P; Martini, D; Orsini, E; Giordano, C ; Pucci, I
Analisi di cluster proteomici per l'identificazione di sottopopolazioni di pazienti con carcinoma mammario
2013-01-01 Albanese, NN; Cancemi, P; Di Cara, G; Musso, R; Lupo, C; Roz E; Riili, I; Pucci, I
Analysis of Trastuzumab effects in breast cancer cells in vitro
2011-01-01 Di Cara, G; Albanese, NN; Musso, R; Costantini, F; Marabeti MR; Cancemi, P; Pucci, I
Anti-oncogenic role of decorin: identification of new markers.
2009-01-01 DI CARA G; MINAFRA L; CANCEMI P; ALBANESE NN; MARABETI MR; FEO S; PUCCI, I
AUTOANTIBODIES IDENTIFICATION IN BREAST CANCER SERA BY PROTEOMIC APPROACH
2011-01-01 Cancemi, P; Albanese, NN; Di Cara, G; Marabeti, MR; Musso, R; Roz, E; Lupo, C; Pucci, I
Breast cancer proteomics: from research to clinical applications.
2008-01-01 PUCCI-MINAFRA I; CANCEMI P; ALBANESE NN; DI CARA G; MARABETI MR; MARRAZZO A; MINAFRA S
Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.)
2005-01-01 GALETTA D; GIOTTA F; ROSATI G; GEBBIA V; MANZIONE L; DI BISCEGLIE M; BORSELLINO N; COLUCCI G; Pucci, I.
CIRCULATING AND TISSUE FORMS OF MMP2 AND MMP9 IN BREAST CANCER PROGRESSION
2010-01-01 Marabeti, MR; Cancemi, P; Pivetti, A; Di Cara, G; Albanese, NN; Costantini, F; Musso, R; Pucci, I
Circulating levels of Matrix Metalloproteinases (MMP-2 and MMP-9), CRP and IL-6 during therapeutic treatment of patients with breast cancer
2008-01-01 MARABETI MR; DI CARA G; CANCEMI P; ALBANESE NN; TAORMINA P; MARRAZZO A; PUCCI-MINAFRA I
Clinicopathological correlations of MMP-2 and MMP-9 in breast cancer
2009-01-01 Marabeti, MR; Cancemi, P; Albanese, NN; Di Cara, G; Costantini, F; Musso, R; Roz, E; Lupo, C; Marrazzo, A; Pucci, I
Comparative detection of matrix metalloproteinase-2 and -9, interleukin-6 and c-reactive protein in breast cancer serum of patients during neoadjuvant chemotherapy
2007-01-01 Marabeti, M.; Cancemi, P.; DI CARA, G.; Albanese, N.; Taormina, P.; Marrazzo, A.; Pucci, I.
Comparative Proteomic and immunohistochemistry analyses to study alphaenolase/MBP-1 isoforms expression in breast cancer
2007-01-01 FERRO A; LO PRESTI M; CANCEMI P; MINAFRA L; LUPO C; ROZ E; MARRAZZO A; PUCCI-MINAFRA I; FEO S
COMPARATIVE PROTEOMIC PROFILING OF NORMAL AND BREAST CANCER CELLS UNDER HYPOXIC CONDITIONS
2010-01-01 ALBANESE, NN; DI CARA, G; MUSSO, R; CANCEMI, P; COSTANTINI, F; MARABETI, MR; FILIPPI, I; CARRARO, F; PUCCI, I
Comparative proteomics of breast cancer surgical tissues
2009-01-01 Albanese, NN; Di Cara, G; Costantini, F; Musso, R; Marabeti, MR; Marrazzo, A; Minafra, S; Pucci, I; Cancemi, P
Correlation between MMPS and proteomic profiles of breast cancer tissues
2009-01-01 Marabeti, MR; Cancemi, P; Pivetti, A; Marrazzo, A; Taormina, P; Pucci, I
Cross-talk between breast cancer cells and fibroblasts in coculture system.
2005-01-01 Cancemi, P.; Marabeti, M.; Albanese, N.; Caricato, S.; Minafra, S.; Pucci, I.
Cross-talk between fibroblast and breast cancer cells: a proteomic study
2003-01-01 Cancemi, P.; LA ROCCA, G.; Barranca, M.; Fontana, S.; Minafra, S.; Pucci, I.
Cytoskeleton and Proteomic Changes Induced by Fibroblasts on Breast Cancer Cells
2007-01-01 Cancemi, P.; Albanese, N.; DI CARA, G.; Minafra, L.; Marabeti, M.; Pucci, I.